GLOBAL NANOPHARMACEUTICALS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Feb 2019 139

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

Scope of the Report:
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.
The worldwide market for Nanopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nanopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Merck
- Pfizer
- Novartis
- Abbott
- GlaxoSmithKline
- Roche
- Sanofi
- Eli Lilly
- Astrazeneca
- Johnson & Johnson
- Celgene
- Novavax
- Stryker
- Gilead Sciences
- OSI Pharmaceuticals
- Kadmon Pharmaceuticals
- Samyang Biopharm
- Mitsubishi Pharma
- Kaken Pharmaceutical
- Selecta Biosciences
- Par Pharmaceutical
- Cerulean Pharma
- Navidea Biopharmaceuticals
- Lummy

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Liposomes
- Polymeric Micelles
- Solid Lipid Nanoparticles
- Microemulsion and Nnanoemulsion
- Nanosuspension

Market Segment by Applications, can be divided into
- Cancer and Tumor
- Autoimmune Disorders
- Inflammation
- Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals in 2017 and 2018.
Chapter 3, the Nanopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Apr 19)

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor ...

(Apr 19)

Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often assoc...

(Apr 19)

Western Blot Imager is an important instrument devices use to study and diagnosis of health conditions and diseases, including HIV. ...

(Apr 19)

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of...

(Apr 19)

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone m...

(Apr 19)

Glucoamylase is a glycoprotein with the molecular weight 60000-100000 containing mannose, glucose, galactose and alduronic acid. It can be u...

GLOBAL NANOPHARMACEUTICALS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy